Whittemore G. Tingley
Chief Medical OfficerDr. Whittemore G. Tingley, also known as Whit, M.D., Ph.D., has been the Chief Medical Officer at Tenaya Therapeutics, Inc. since December 2018. Dr. Tingley was Vice President of Clinical Research, Cardiology at Cytokinetics, Incorporated since September 2017 until December 2018. Prior to joining Cytokinetics, Dr. Tingley served as the Therapeutic Area Lead for Cardiovascular and Metabolism Research and Early Development at Genentech. From 2009 to September 2017, he held Medical Director and Group Medical Director roles with increasing responsibility at Genentech, Roche and CardioDx. Previously, he worked in the Cardiology Division at the University of California, San Francisco as an Adjunct Associate Professor of Medicine and cared for patients as an Attending Cardiologist in the UCSF Cardiology Faculty Practice. He completed internship and residency programs in internal medicine at the Johns Hopkins Hospital and a cardiology fellowship at UCSF. He earned M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine and an A.B. degree from Brown University.
Positions
- Company NameTenaya Therapeutics, Inc.Stock CodeTNYAPositionChief Medical OfficerColleagues
- FAFaraz AliPresident, CEO & Director
- DSDeepak SrivastavaScientific Founder, Chairman of Scientific Advisory Board & Director
- ENEric N. OlsonScientific Founder & Member of Scientific Advisory Board
- BRBruce R. ConklinScientific Founder
- JTJeffrey T. WalshIndependent Director
- JHJune H. LeeIndependent Director
